Business Description
Kardigan Inc
NAICS : 325412
SIC : 2834
ISIN : US4859251013
Description
Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 24.25 | |||||
Equity-to-Asset | -0.64 | |||||
Debt-to-Equity | -0.06 | |||||
Debt-to-EBITDA | -0.07 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 9.2 | |||||
Quick Ratio | 9.2 | |||||
Cash Ratio | 8.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -84.47 | |||||
ROIC % | -495.18 | |||||
ROC (Joel Greenblatt) % | -1374.58 | |||||
ROCE % | -98.78 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -7.54 | |||||
EV-to-EBITDA | -7.77 | |||||
EV-to-FCF | -9.65 | |||||
Earnings Yield (Greenblatt) % | -13.26 | |||||
FCF Yield % | -8.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KARD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kardigan Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -3.2 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 42.07 | ||
| 14-Day ATR ($) | 1.904714 | ||
| 20-Day SMA ($) | 21.8877 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 16.25 - 27 | ||
| Shares Outstanding (Mil) | 89.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kardigan Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kardigan Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kardigan Inc Frequently Asked Questions
What is Kardigan Inc(KARD)'s stock price today?
The current price of KARD is $20.10. The 52 week high of KARD is $27.00 and 52 week low is $16.25.
When is next earnings date of Kardigan Inc(KARD)?
The next earnings date of Kardigan Inc(KARD) is .
Does Kardigan Inc(KARD) pay dividends? If so, how much?
Kardigan Inc(KARD) does not pay dividend.
Guru Commentaries on NAS:KARD
No articles.
Press Release
Articles on Kardigan Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers